Peptides promoting the activation of latent tgf-.beta. and method for screening tgf-.beta. activity regulators
CA 2259956 A1 · Owner: Shibata, Kenji · Inventors: Shibata, Kenji; Yamasaki, Motoo; Sato, Yasufumi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Peptides represented by the following general formula (I) and having the activity of promoting the liberation of active TGF-.beta. from latent TGF- .beta. or the activity of promoting the binding of latent TGF-.beta. to cell membrane; a method for screening compounds for preventing or treating diseases in which TGF-.beta. participates by assaying the above activities; and the compounds thus obtained. The peptides and compounds described above are useful as remedies or preventives for cancer, diabetic retinitis atherosclerosis, etc. General formula (I): R1-A-R2 wherein R1 represents hydrogen, optionally substituted alkanoyl, etc.; R2 represents hydroxy or optionally substituted alkoxy …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 12, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 12, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 12, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.